Status:
COMPLETED
Hospital Outcomes: Intervention in Moderately III Patients
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian Hospital
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To evaluate the utility of real time prognostic data (illness severity, stability and function) in the improvement of hospitalization morbidity, mortality, iatrogenic complications and length of stay.
Detailed Description
To evaluate resource allocation and efficiency of ancillary service delivery in aggregate cost and 3 month follow up in regards to hospital readmission, living environment, and utilization of social s...
Eligibility Criteria
Inclusion
- All medical in-patients who are coded moderately ill with fair to poor function in the SIGNOUT program will be asked to participate in our study.
- Patients who are able to provide verbal consent for their participation will be enrolled.
Exclusion
- Any patient not coded in the SIGNOUT system as moderately ill with fair to poor function.
- Patients who refuses not to participate in the study.
- Patients who are unable to give written informed consent.
Key Trial Info
Start Date :
September 1 1998
Trial Type :
INTERVENTIONAL
End Date :
April 1 1999
Estimated Enrollment :
444 Patients enrolled
Trial Details
Trial ID
NCT00256659
Start Date
September 1 1998
End Date
April 1 1999
Last Update
April 3 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Presbyterian Hospital- Weill Medical Center
New York, New York, United States, 10021